KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Return on Sales (2016 - 2025)

Historic Return on Sales for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to 0.28%.

  • Dynavax Technologies' Return on Sales rose 700.0% to 0.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year decrease of 2100.0%. This contributed to the annual value of 0.1% for FY2024, which is 1300.0% up from last year.
  • As of Q3 2025, Dynavax Technologies' Return on Sales stood at 0.28%, which was up 700.0% from 0.2% recorded in Q2 2025.
  • Dynavax Technologies' 5-year Return on Sales high stood at 0.51% for Q4 2021, and its period low was 1.41% during Q1 2025.
  • In the last 5 years, Dynavax Technologies' Return on Sales had a median value of 0.2% in 2025 and averaged 0.07%.
  • As far as peak fluctuations go, Dynavax Technologies' Return on Sales soared by 104800bps in 2021, and later tumbled by -12400bps in 2025.
  • Quarter analysis of 5 years shows Dynavax Technologies' Return on Sales stood at 0.51% in 2021, then dropped by -28bps to 0.37% in 2022, then crashed by -99bps to 0.0% in 2023, then skyrocketed by 2385bps to 0.1% in 2024, then surged by 190bps to 0.28% in 2025.
  • Its last three reported values are 0.28% in Q3 2025, 0.2% for Q2 2025, and 1.41% during Q1 2025.